Abiomed, Inc.ABMDNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank64
3Y CAGR+13.1%
5Y CAGR+10.2%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
+13.1%/yr
vs -35.1%/yr prior
5Y CAGR
+10.2%/yr
Consistent
Acceleration
+48.2pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202262.35%
2021-7.89%
202010.86%
201943.07%
201874.33%
201738.45%
2016127.11%
2015242.77%
2014-49.45%
2013988.36%